Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for OnCure Holdings, Inc. > News item |
OnCure announces Oct. 25 effective date for plan of reorganization
By Jim Witters
Wilmington, Del., Oct. 28 - OnCure Holdings, Inc. has substantially consummated its Chapter 11 plan of reorganization and the plan effective date occurred on Oct. 25, according to an Oct. 25 filing with the U.S. Bankruptcy Court for the District of Delaware.
As previously reported, the court confirmed the reorganization plan on Oct. 3.
Radiation Therapy Services, Inc. agreed to buy 100% of the shares of the reorganized holding company and pay $42.5 million in cash and guarantee $82.5 million of amended secured notes.
The sale proceeds leave senior secured noteholders with a $100 million deficiency on their claims, but the transaction and reorganization presented the best alternative for OnCure creditors, attorneys for the debtors and the noteholders said.
Creditor treatment
Treatment of creditors under the confirmed plan includes the following:
• Debtor-in-possession facility claims will be paid in full in cash;
• Pre-bankruptcy term loan claims will be paid in full on the effective date, to the extent not previously paid in full under DIP facility orders;
• The principal amount of pre-bankruptcy secured notes will be reduced to $82.5 million.
Noteholders will receive a share of base notes and a net cash amount.
Noteholders will receive a share of either the sum of the amount by which the final purchase price exceeds the initial purchase price if the final price is greater plus an escrow amount or, if the final purchase price is equal to or less than the initial price, an amount equal to the escrow amount following distribution to the investor.
Noteholders also will receive an unused cash reserve amount and a share of any escrowed notes;
• Holders of general unsecured claims and old holding company interests will not receive any recovery; and
• Old affiliate interests in any holding company subsidiary will remain effective and will still be owned by the same holder that owned them immediately before the effective date.
OnCure is an Englewood, Colo.-based provider of business management services and medical equipment to oncology physician groups that treat cancer patients. Its Chapter 11 case number is 13-11540.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.